Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of LifePoint Health, Inc. (NASDAQ:LPNT) by 10.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,678 shares of the company’s stock after purchasing an additional 164 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in LifePoint Health were worth $113,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in LPNT. BlackRock Inc. boosted its stake in shares of LifePoint Health by 11,671.9% during the 1st quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after purchasing an additional 3,714,004 shares during the period. Point72 Asset Management L.P. boosted its stake in shares of LifePoint Health by 291.1% during the 1st quarter. Point72 Asset Management L.P. now owns 688,352 shares of the company’s stock worth $45,087,000 after purchasing an additional 512,352 shares during the period. Victory Capital Management Inc. boosted its stake in shares of LifePoint Health by 130.6% during the 2nd quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock worth $54,804,000 after purchasing an additional 462,211 shares during the period. UBS Asset Management Americas Inc. boosted its stake in shares of LifePoint Health by 679.9% during the 1st quarter. UBS Asset Management Americas Inc. now owns 247,499 shares of the company’s stock worth $16,211,000 after purchasing an additional 215,763 shares during the period. Finally, Goldman Sachs Group Inc. boosted its stake in shares of LifePoint Health by 103.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 408,284 shares of the company’s stock worth $26,742,000 after purchasing an additional 208,084 shares during the period. 99.53% of the stock is owned by hedge funds and other institutional investors.

Shares of LifePoint Health, Inc. (LPNT) opened at 57.20 on Friday. The stock has a 50 day moving average of $57.25 and a 200 day moving average of $61.82. LifePoint Health, Inc. has a 12-month low of $50.60 and a 12-month high of $70.95. The company has a market cap of $2.29 billion, a price-to-earnings ratio of 12.81 and a beta of 0.85.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.69 earnings per share. The business’s revenue for the quarter was up .2% compared to the same quarter last year. Analysts forecast that LifePoint Health, Inc. will post $4.06 earnings per share for the current year.

In other news, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the completion of the transaction, the chairman now owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 7.28% of the company’s stock.

Several equities research analysts have issued reports on LPNT shares. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research report on Monday, August 21st. ValuEngine raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. BidaskClub cut shares of LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. TheStreet cut shares of LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $77.00 price objective on shares of LifePoint Health in a research report on Wednesday, July 5th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $66.18.

TRADEMARK VIOLATION WARNING: “LifePoint Health, Inc. (LPNT) Position Boosted by Zurcher Kantonalbank Zurich Cantonalbank” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/09/24/lifepoint-health-inc-lpnt-position-boosted-by-zurcher-kantonalbank-zurich-cantonalbank.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health, Inc. (NASDAQ:LPNT).

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.